CCCC vs CLOV
C4 Therapeutics Inc (CCCC) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
CCCC currently screens at market cap $425.7M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the CCCC and CLOV stock pages for the full models.
Not investment advice.